Compare SRPT & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRPT | TXG |
|---|---|---|
| Founded | 1980 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.8B |
| IPO Year | 2000 | 2019 |
| Metric | SRPT | TXG |
|---|---|---|
| Price | $18.83 | $19.08 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 28 | 14 |
| Target Price | ★ $25.76 | $16.82 |
| AVG Volume (30 Days) | 2.3M | ★ 2.5M |
| Earning Date | 04-17-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 140.34 | 76.97 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,901,979,000.00 | $245,893,000.00 |
| Revenue This Year | $14.67 | N/A |
| Revenue Next Year | N/A | $7.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 52.97 | ★ 68.06 |
| 52 Week Low | $10.42 | $6.78 |
| 52 Week High | $109.55 | $23.56 |
| Indicator | SRPT | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 43.14 | 51.38 |
| Support Level | $17.45 | $17.26 |
| Resistance Level | $18.70 | $19.78 |
| Average True Range (ATR) | 1.00 | 1.31 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 37.11 | 61.02 |
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).